In principle, genetic engineering is simple, but in practice, replacing a faulty gene with a healthy copy is anything but. Using mutated versions of the lamin A gene as an example to demonstrate the versatility of their virus-based approach, researchers successfully edited a diseased gene in patient-specific induced pluripotent stem cells as well as adult stem cells.